✦ LIBER ✦

Population Dynamics Studies of Wild-Type and Drug-Resistant Mutant HIV in Mixed Infections

✍ Scribed by Marlene M. Rayner; Beverly Cordova; David A. Jackson

Book ID: 112271612
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 890 KB
Volume: 236
Category: Article
ISSN: 0042-6822
DOI: 10.1006/viro.1997.8620

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In silicoanalysis of drug resistance in

In silicoanalysis of drug resistance in wild type and mutant HIV-1 subtype d protease

✍ Munusami, Punnagai; Vasavi, CS 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 83 KB

Overcoming drug resistance in HIV-1 chem

Overcoming drug resistance in HIV-1 chemotherapy: The binding thermodynamics of Amprenavir and TMC-126 to wild-type and drug-resistant mutants of the HIV-1 protease

✍ Hiroyasu Ohtaka; Adrian Velázquez-Campoy; Dong Xie; Ernesto Freire 📂 Article 📅 2002 🏛 Cold Spring Harbor Laboratory Press 🌐 English ⚖ 243 KB

Molecular Dynamics Studies of the Wild-T

Molecular Dynamics Studies of the Wild-Type and Double Mutant HIV-1 Integrase Complexed with the 5CITEP Inhibitor: Mechanism for Inhibition and Drug Resistance

✍ Barreca, Maria L.; Lee, Keun Woo; Chimirri, Alba; Briggs, James M. 📂 Article 📅 2003 🏛 Biophysical Society 🌐 English ⚖ 549 KB

Molecular Dynamics and Free Energy Studi

Molecular Dynamics and Free Energy Studies on the Wild-type and Double Mutant HIV-1 Protease Complexed with Amprenavir and Two Amprenavir-Related Inhibitors: Mechanism for Binding and Drug Resistance

✍ Hou, Tingjun; Yu, Ron 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 897 KB

Transmitted drug resistance and type of

Transmitted drug resistance and type of infection in newly diagnosed HIV-1 individuals in Honduras

✍ Wendy Murillo; Gabriela Paz-Bailey; Sonia Morales; Edgar Monterroso; Mayte Pared 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Anti-viral Drug Treatment: Dynamics of R

Anti-viral Drug Treatment: Dynamics of Resistance in Free Virus and Infected Cell Populations

✍ Martin A. Nowak; Sebastian Bonhoeffer; George M. Shaw; Robert M. May 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 434 KB

Anti-viral drug treatment of infections with the human immunodeficiency virus type I (HIV-1) usually leads to a rapid decline in the abundance of plasma virus. The effect of single drug therapy, however, is often only short-lived as the virus readily develops drug-resistant mutants. In this paper we